| Reviews |
 |
|
|
|
|
Reviews to:
Date: Wednesday, 28. October 2015
Author: Gast
Review:
Go travelling ondansetron 4 mg FMC, a New York-based investment advisory firm, hasrepeatedly criticized Vivus saying it badly mishandled thelaunch of its obesity drug Qsymia and failed to land a largecompany partner with deep pockets and a big enough sales forceto help the drug reach its blockbuster potential.
Evaluation:  |
|
|
|
| Shopping Cart |
 |
|
| You do not have any products in your shopping cart yet. |
|
|
Customer group:Guest
|
|
|
|
